← Back to Analyst Consensus 
MIRM Buy
Mirum Pharmaceuticals, Inc.
Current Price —
Implied Upside —
Analysts 20
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 10 reiterations from 8 firms
Next Earnings
Nov 17, 2026 (22 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Oct 15, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Oct 13, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Oct 13, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Oct 12, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Oct 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Oct 8, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Sep 29, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Sep 29, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Sep 28, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 27, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Aug 6, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 6, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 6, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Aug 6, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 2, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Jun 15, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 47% |
| Jun 11, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| Jun 2, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| May 19, 2026 | Wolfe Research | initiate | — → Outperform | — | 53% |
| May 7, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| May 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 7, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| May 7, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| May 5, 2026 | Morgan Stanley | maintain | Overweight → Overweight | — | 54% |
| May 4, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Apr 29, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Apr 28, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Apr 27, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Apr 21, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Mar 27, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Mar 23, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 4, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Feb 26, 2026 | Leerink Partners | maintain | Outperform → Outperform | $118 | 51% |
| Feb 26, 2026 | TD Cowen | maintain | Buy → Buy | $117 | 54% |
| Feb 26, 2026 | RBC Capital | maintain | Outperform → Outperform | $128 | 55% |
| Feb 26, 2026 | Citizens | maintain | Market Outperform → Market Outperform | $132 | 47% |
| Feb 26, 2026 | Stifel | maintain | Buy → Buy | $125 | 53% |
| Feb 18, 2026 | RBC Capital | initiate | — → Outperform | $130 | 55% |
| Jan 30, 2026 | Morgan Stanley | maintain | Overweight → Overweight | $123 | 54% |
| Jan 26, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $130 | 44% |
| Jan 13, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $102 | 44% |
| Dec 19, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $140 | 47% |
| Dec 16, 2025 | Stifel | maintain | Buy → Buy | $98 | 53% |
| Dec 9, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $95 | 54% |
| Dec 9, 2025 | Baird | maintain | Outperform → Outperform | $88 | 55% |
| Dec 9, 2025 | Evercore ISI Group | maintain | Outperform → Outperform | $94 | 58% |
| Dec 8, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $130 | 50% |
| Nov 5, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $95 | 50% |
Price Target Trend
Jun 1, 2026 Latest: $153.43 Oct 24, 2026
EPS Estimates
+1y $-0.70
Lo: $-1.24 Hi: $-0.17
2 analysts +1q $-0.44
Lo: $-0.44 Hi: $-0.44
1 analysts ▲1
0q $-0.41
Lo: $-0.53 Hi: $-0.30
2 analysts 0y $-15.23
Lo: $-15.23 Hi: $-15.23
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days